Apolipoprotein E in Health and Disease
Academic Press Inc (Verlag)
978-0-443-40563-1 (ISBN)
- Noch nicht erschienen (ca. April 2026)
- Versandkostenfrei
- Auch auf Rechnung
- Artikel merken
In addition, the book extends its exploration to the broader influence of ApoE on cognitive decline and other neurological conditions, metabolic health, liver function, cancer risk, and immune modulation. With a strong focus on the pharmacogenetics of ApoE, the book paves the way for precision medicine, offering insights into how ApoE genotypes influence medication responses and therapeutic strategies. Future prospects and challenges in harnessing ApoE for disease management are discussed, alongside its role in infectious diseases, genetic engineering innovations, and targeted drug delivery systems.
Dileep Kumar received his B. Pharm from Manipal College of Pharmaceutical Sciences, Manipal University, and M. Pharm from S.G.S.I.T.S Indore, Madhya Pradesh. He has several patents to his credit. He was awarded a Junior Research fellowship by National Medicinal Plant Board (NMPB) New Delhi, Senior Research Fellowship from University Grants Commission (UGC), Teaching Assistantship, and institute Post-Doctoral fellowship from IIT (BHU) Varanasi. At present, he is teaching as an assistant professor at Poona College of pharmacy, Bharti Vidyapeeth University Pune. He has published many papers and patents. He is Guest editor of several Prestigious journals. At present he is visiting professor in the department of entomology and Comprehensive Cancer Center in university of California Davis Dr. Ganeshpurkar's primary goal is to establish a distinct presence in the realm of medicinal chemistry and drug design research, with a specific focus on harnessing computational tools and artificial intelligence to advance the processes of lead discovery and optimization. His research is centred around in silico drug design, lead identification, and optimization. Additionally, his work encompasses the design, synthesis, and thorough biological assessment of novel leads tailored to address diverse pathophysiological conditions, including but not limited to Alzheimer's disease and various neurodegenerative disorders. Dr. Aditya Ganeshpurkar holds a Ph.D. in pharmacology and has extensive experience in both academics and research. His research primarily focuses on pharmacological and nutraceutical studies, with an emphasis on drug discovery, evaluation, and immunomodulation. Dr. Ganeshpurkar has published numerous research articles, review articles, and book chapters in various scientific journals and has presented his work at national seminars and conferences. His research areas include the evaluation of herbal and synthetic drugs, immunomodulatory potential, and the development of drug delivery systems. He has more than 3000 citations with h index of 28 and holds a place in top 2% of scientist in the pharmacy field.
1. Apolipoprotein E (ApoE): Structural Insights, Functionality, and Genetic Variability
2. Apolipoprotein E and Cardiovascular Pathophysiology: A Comprehensive Exploration
3. Apolipoprotein E in Alzheimer's Disease: Genetic Predisposition and Mechanistic Implications
4. Apolipoprotein E and Neurological Disorders: Beyond Alzheimer's Disease
5. Apolipoprotein E's Impact on Metabolic Syndrome: A Systematic Analysis
6. Apolipoprotein E and Liver Health: Implications in Lipid Metabolism and Disease
7. Apolipoprotein E and its Role in Cancer: Insights into Carcinogenic Associations
8. Apolipoprotein E's Immune Mediation: Implications in Inflammatory Disorders
9. Pharmacogenetics of Apolipoprotein E: Precision Medicine and Therapeutic Implications
10. Challenges and Prospects in Targeting ApoE for Disease Management
11. Apolipoprotein E and Infectious Diseases: A Framework for Therapeutic Developments
12. Genetic Engineering of Apolipoprotein E: Innovations and Clinical Applications
13. Apolipoprotein E and Precision Medicine: Individualized Disease Management Approaches
14. Apolipoprotein E in Drug Delivery Systems: Targeted Pharmacotherapeutics
15. Apolipoprotein E and Autoimmune Disorders: Therapeutic Frontiers
| Erscheint lt. Verlag | 3.4.2026 |
|---|---|
| Verlagsort | San Diego |
| Sprache | englisch |
| Maße | 191 x 235 mm |
| Gewicht | 450 g |
| Themenwelt | Naturwissenschaften ► Biologie ► Genetik / Molekularbiologie |
| ISBN-10 | 0-443-40563-8 / 0443405638 |
| ISBN-13 | 978-0-443-40563-1 / 9780443405631 |
| Zustand | Neuware |
| Informationen gemäß Produktsicherheitsverordnung (GPSR) | |
| Haben Sie eine Frage zum Produkt? |
aus dem Bereich
